Rx — Prescription Required
ART Combination
INBEC
Abacavir + Dolutegravir + Lamivudine
Manufacturer
Emcure Pharmaceuticals
Pack Size
30 Tablets
Category
ART Combination
Prescription Status
Rx — Required
✓ Plain unmarked packaging
✓ No HIV branding on parcel
✓ Tamper-proof sealing
About INBEC
Fixed-dose triple combination of Abacavir, Dolutegravir (integrase inhibitor), and Lamivudine. Used as first- or second-line ART for adults. The dolutegravir component provides a high genetic barrier to resistance.
Dosage & Administration
One tablet once daily with or without food. Screen for HLA-B*5701 before initiating Abacavir.
Dosage information is indicative only. Always follow the schedule prescribed by your physician.
Storage
Store below 30°C in a cool, dry place away from direct sunlight. Keep out of reach of children.
INBEC is a Schedule H drug. A valid prescription from a licensed medical practitioner is mandatory. This page is for informational purposes only and is not medical advice — consult your HIV physician before starting, changing, or stopping any antiretroviral therapy.
